Skip to main content
. 2021 Sep 2;163(6):e738–e747. doi: 10.1097/j.pain.0000000000002470

Table 3.

Change from baseline in the average pain intensity score using mixed-model repeated-measures, intent-to-treat population.

Visit No. of patients Least-square estimates (mean) Treatment A-B
ISC 17536 (treatment A) Placebo (treatment B) ISC 17536 Placebo LS mean difference 95% confidence interval
Week 1 70 66 −0.86 −0.46 −0.40 (−0.89, 0.09)
Week 2 70 65 −1.24 −1.02 −0.22 (−0.71, 0.28)
Week 3 65 62 −1.65 −1.33 −0.32 (−0.82, 0.18)
Week 4 70 66 −1.95 −1.68 −0.27 (−0.76, 0.22)
Week 6 63 62 −2.41 −2.16 −0.25 (−0.75, 0.26)

Model: Change from baseline in the API score = treatment + week + treatment*week + baseline API + patient as a random effect.

ITT, intent-to-treat.